Susquehanna International Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Sell
249,090
-134,220
-35% -$7.64M 0.02% 2368
2025
Q4
$16.2M Sell
383,310
-541,586
-59% -$30.3M 0.02% 2447
2025
Q3
$52.6M Buy
924,896
+703,005
+317% +$23.3M 0.08% 1304
2025
Q2
$5.73M Buy
221,891
+184,744
+497% +$2.07M 0.01% 3725
2025
Q1
$379K Buy
37,147
+31,594
+569% +$413K ﹤0.01% 9532
2024
Q4
$77.5K Buy
+5,553
New +$97.9K ﹤0.01% 11487
2024
Q3
Sell
-4,329
Closed -$82.5K 12812
2024
Q2
$80.5K Sell
4,329
-21,071
-83% -$444K ﹤0.01% 11168
2024
Q1
$356K Buy
25,400
+19,986
+369% +$209K ﹤0.01% 9300
2023
Q4
$45.9K Sell
5,414
-3,949
-42% -$29.9K ﹤0.01% 11741
2023
Q3
$83.6K Sell
9,363
-16,274
-63% -$157K ﹤0.01% 11044
2023
Q2
$221K Buy
25,637
+14,496
+130% +$155K ﹤0.01% 10074
2023
Q1
$117K Buy
11,141
+8,160
+274% +$247K ﹤0.01% 11146
2022
Q4
$101K Sell
2,981
-7,369
-71% -$357K ﹤0.01% 10952
2022
Q3
$497K Buy
10,350
+2,869
+38% +$171K ﹤0.01% 8508
2022
Q2
$426K Buy
7,481
+1,254
+20% +$79.1K ﹤0.01% 8659
2022
Q1
$503K Sell
6,227
-9,328
-60% -$1.38M ﹤0.01% 8952
2021
Q4
$3.15M Buy
15,555
+12,383
+390% +$2.69M ﹤0.01% 4562
2021
Q3
$855K Sell
3,172
-671
-17% -$161K ﹤0.01% 7974
2021
Q2
$989K Buy
3,843
+1,112
+41% +$308K ﹤0.01% 7794
2021
Q1
$819K Sell
2,731
-10,756
-80% -$3.35M ﹤0.01% 8249
2020
Q4
$3.44M Buy
13,487
+4,203
+45% +$1.09M 0.01% 4074
2020
Q3
$2.31M Sell
9,284
-5,133
-36% -$1.61M ﹤0.01% 4342
2020
Q2
$5.01M Buy
14,417
+3,184
+28% +$994K 0.01% 3008
2020
Q1
$3.01M Sell
11,233
-23,552
-68% -$7.28M 0.01% 3279
2019
Q4
$11.3M Sell
34,785
-15,557
-31% -$4.51M 0.02% 1963
2019
Q3
$13.8M Buy
50,342
+12,815
+34% +$4.7M 0.03% 1657
2019
Q2
$20M Buy
37,527
+3,590
+11% +$1.8M 0.05% 1278
2019
Q1
$17.1M Buy
33,937
+749
+2% +$444K 0.08% 1299
2018
Q4
$16.4M Buy
33,188
+11,474
+53% +$6.93M 0.07% 1206
2018
Q3
$19.9M Sell
21,714
-18,347
-46% -$15.7M 0.07% 1338
2018
Q2
$29.3M Sell
40,061
-616
-2% -$710K 0.1% 1008
2018
Q1
$64.8M Sell
40,677
-11,698
-22% -$15.1M 0.22% 554
2017
Q4
$46.9M Buy
52,375
+24,825
+90% +$14.7M 0.16% 716
2017
Q3
$9.92M Buy
27,550
+3,864
+16% +$1.21M 0.04% 1778
2017
Q2
$6.95M Buy
23,686
+6,784
+40% +$1.96M 0.03% 2030
2017
Q1
$5.95M Sell
16,902
-3,954
-19% -$889K 0.03% 2170
2016
Q4
$3.84M Buy
20,856
+18,711
+872% +$3.8M 0.02% 2845
2016
Q3
$553K Buy
+2,145
New +$552K ﹤0.01% 5886
2016
Q2
Sell
-1,194
Closed -$267K 9255
2016
Q1
$246K Buy
1,194
+18
+2% +$3.46K ﹤0.01% 7597
2015
Q4
$297K Sell
1,176
-3,216
-73% -$661K ﹤0.01% 7706
2015
Q3
$722K Buy
4,392
+2,484
+130% +$439K ﹤0.01% 6406
2015
Q2
$358K Sell
1,908
-3,533
-65% -$608K ﹤0.01% 8244
2015
Q1
$898K Buy
5,441
+2,167
+66% +$445K ﹤0.01% 5968
2014
Q4
$761K Buy
+3,274
New +$700K ﹤0.01% 6397
2014
Q3
Sell
-3,432
Closed -$657K 9825
2014
Q2
$660K Buy
3,432
+1,237
+56% +$219K ﹤0.01% 6925
2014
Q1
$399K Sell
2,195
-704
-24% -$139K ﹤0.01% 7116
2013
Q4
$494K Sell
2,899
-7,196
-71% -$1.16M ﹤0.01% 6714
2013
Q3
$1.58M Buy
10,095
+8,154
+420% +$1.51M ﹤0.01% 4506
2013
Q2
$336K Buy
+1,941
New +$298K ﹤0.01% 6620

Other funds holding NKTR